EdgarLookup

WM TECHNOLOGY, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that WM TECHNOLOGY, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
1.1%
Profit Margin
Net income ÷ revenue
1%
Return on Assets
Net income ÷ assets
1.03x
Debt-to-Equity
Total liabilities ÷ equity
-5.3%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $174.70M Mar 12, 2026
FY2025 Dec 31, 2024 $184.51M Mar 12, 2026
FY2024 Dec 31, 2023 $187.99M Mar 13, 2025
FY2023 Sep 30, 2023 $46.69M May 24, 2024
FY2023 Jun 30, 2023 $48.42M May 24, 2024
FY2023 Mar 31, 2023 $46.42M May 24, 2024
FY2023 Dec 31, 2022 $215.53M May 24, 2024
FY2023 Dec 31, 2021 $193.15M May 24, 2024
FY2022 Dec 31, 2020 $161.79M Mar 16, 2023
FY2021 Dec 31, 2019 $144.23M Feb 25, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.96M Mar 12, 2026
FY2025 Dec 31, 2024 $7.64M Mar 12, 2026
FY2024 Dec 31, 2023 ($9.90M) Mar 13, 2025
FY2023 Dec 31, 2022 ($115.99M) May 24, 2024
FY2023 Dec 31, 2021 $137.10M May 24, 2024
FY2022 Dec 31, 2020 $38.83M Mar 16, 2023
FY2020 Sep 30, 2020 ($1.42M) May 12, 2021
FY2020 Jun 30, 2020 ($3.15M) May 12, 2021
FY2020 Mar 31, 2020 $1.82M May 12, 2021
FY2020 Dec 31, 2019 $5.35M May 12, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $766.0K Mar 12, 2026
FY2025 Dec 31, 2024 $14.77M Mar 12, 2026
FY2024 Dec 31, 2023 ($18.46M) Mar 13, 2025
FY2023 Dec 31, 2022 ($69.62M) May 24, 2024
FY2023 Dec 31, 2021 ($8.18M) May 24, 2024
FY2022 Dec 31, 2020 $41.20M Mar 16, 2023
FY2020 Dec 31, 2019 ($586.8K) May 12, 2021

R&D Expense

Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $28.14M Mar 12, 2026
FY2025 Dec 31, 2024 $36.43M Mar 12, 2026
FY2024 Dec 31, 2023 $36.00M Mar 13, 2025
FY2023 Dec 31, 2022 $50.52M May 24, 2024
FY2023 Dec 31, 2021 $35.40M May 24, 2024
FY2022 Dec 31, 2020 $27.14M Mar 16, 2023
FY2021 Dec 31, 2019 $29.50M Feb 25, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $26.19M Mar 12, 2026
FY2025 Dec 31, 2024 $36.68M Mar 12, 2026
FY2024 Dec 31, 2023 $22.93M Mar 13, 2025
FY2023 Dec 31, 2022 ($11.62M) May 24, 2024
FY2023 Dec 31, 2021 $30.19M May 24, 2024
FY2022 Dec 31, 2020 $39.24M Mar 16, 2023
FY2020 Dec 31, 2019 ($467.0K) May 12, 2021

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $16.06M Mar 16, 2023
FY2022 Dec 31, 2021 $7.94M Mar 16, 2023
FY2022 Dec 31, 2020 $1.31M Mar 16, 2023
FY2021 Dec 31, 2019 $5.13M Feb 25, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $190.67M Mar 12, 2026
FY2025 Dec 31, 2024 $181.87M Mar 12, 2026
FY2024 Dec 31, 2023 $167.02M Mar 13, 2025
FY2023 Dec 31, 2022 $199.04M May 24, 2024
FY2022 Dec 31, 2021 $365.14M Mar 16, 2023
FY2021 Dec 31, 2020 $53.89M Feb 25, 2022
FY2020 Dec 31, 2019 $253.08M May 12, 2021

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $58.87M Mar 12, 2026
FY2025 Dec 31, 2024 $61.80M Mar 12, 2026
FY2024 Dec 31, 2023 $63.87M Mar 13, 2025
FY2023 Dec 31, 2022 $84.26M May 24, 2024
FY2022 Dec 31, 2021 $233.20M Mar 16, 2023
FY2021 Dec 31, 2020 $24.62M Feb 25, 2022
FY2020 Sep 30, 2020 $26.60M May 12, 2021
FY2020 Jun 30, 2020 $25.24M May 12, 2021
FY2020 Mar 31, 2020 $22.23M May 12, 2021
FY2020 Dec 31, 2019 $22.11M May 12, 2021

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $57.18M Mar 12, 2026
FY2025 Dec 31, 2024 $36.08M Mar 12, 2026
FY2024 Dec 31, 2023 $16.38M Mar 13, 2025
FY2023 Dec 31, 2022 $13.38M May 24, 2024
FY2022 Dec 31, 2021 $63.56M Mar 16, 2023
FY2021 Dec 31, 2020 $0 Feb 25, 2022
FY2020 Dec 31, 2019 $5.00M May 12, 2021
FY2020 Jun 6, 2019 $0 May 12, 2021

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $61.27M Mar 12, 2026
FY2025 Dec 31, 2024 $68.37M Mar 12, 2026
FY2025 Dec 31, 2023 $68.37M Mar 12, 2026
FY2023 Dec 31, 2022 $68.37M May 24, 2024
FY2022 Dec 31, 2021 $45.30M Mar 16, 2023
FY2022 Dec 31, 2020 $3.96M Mar 16, 2023

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($54.92M) Mar 12, 2026
FY2025 Dec 31, 2024 ($56.88M) Mar 12, 2026
FY2024 Dec 31, 2023 ($64.52M) Mar 13, 2025
FY2023 Dec 31, 2022 ($54.62M) May 24, 2024
FY2022 Dec 31, 2021 $61.37M Mar 16, 2023
FY2021 Dec 31, 2020 $0 Feb 25, 2022
FY2020 Sep 30, 2020 $2.26M May 12, 2021
FY2020 Jun 30, 2020 $3.67M May 12, 2021
FY2020 Mar 31, 2020 $5.00M May 12, 2021
FY2020 Dec 31, 2019 $5.00M May 12, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $62.40M Mar 12, 2026
FY2025 Dec 31, 2024 $51.97M Mar 12, 2026

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2021 129.24M May 24, 2024